Doctor-prescribed peptides, shipped to your door.

Surgery, sedation, and procedure planning

Peptide therapy before surgery or procedures: questions to ask your care team

A clinician-safe checklist for GLP-1s, anesthesia, dental work, sedation, procedure timing, missed doses, non-GLP products, pharmacy labels, and urgent symptoms before surgery or procedures.

Educational guideUpdated May 15, 2026

Procedure-ready medication checklist

1

List the exact active ingredient, route, product status, pharmacy label, last-use timing, and why the product is used.

2

Name the procedure: surgery, endoscopy, dental work, imaging, cosmetic procedure, local anesthesia, deep sedation, or general anesthesia.

3

Flag symptoms and risks: nausea, vomiting, reflux, constipation, dehydration, diabetes medicines, blood thinners, infection, pregnancy questions, allergy history, and prior anesthesia problems.

4

Ask who coordinates instructions: surgeon, anesthesiologist, dentist, proceduralist, peptide prescriber, pharmacist, primary care, cardiology, endocrinology, or another specialist.

5

Avoid universal hold charts, seller restart schedules, research-use recovery products, and no-prescription peptide advice around procedures.

Direct answer

Before surgery, sedation, endoscopy, dental work, imaging with anesthesia, or cosmetic procedures, disclose every peptide or peptide-adjacent product to the procedure team and prescriber. Do not self-hold, restart, split, or make up doses. Ask for written, individualized instructions based on the exact medication, route, symptoms, and procedure type.

Disclose the whole list

Procedure teams need active ingredients, not just brand or clinic names

A safe procedure review starts with the exact medication list: semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu, methylene blue, hormones, supplements, blood thinners, diabetes medicines, sleep medicines, pain medicines, and antibiotics. Include compounded prescriptions and pharmacy labels so the team can see concentration, route, storage, and contact information.

  • Say clearly when a medication is compounded. Compounded finished products are not FDA-approved in the same way as approved brand-name drugs.
  • Bring or upload photos of labels, medication instructions, allergy lists, recent side effects, and recent dose changes when the care team asks.
  • Ask whether old records, labs, vitals, medical clearance, specialist input, or pharmacy confirmation are needed before the procedure date.

Anesthesia and GLP-1s

GLP-1 procedure planning is individualized, especially with GI symptoms

Semaglutide and tirzepatide can delay stomach emptying and may cause nausea, vomiting, reflux, constipation, dehydration, or reduced intake. Current multi-society anesthesia guidance says many lower-risk patients can continue GLP-1 medicines before elective surgery, while higher-risk patients may need individualized precautions. Your answer should come from the prescriber and procedure or anesthesia team, not from a generic online washout rule.

  • Important details include recent dose escalation, active GI symptoms, gastroparesis history, diabetes medicines, kidney risk, procedure urgency, and depth of sedation or anesthesia.
  • Urgent or emergency procedures should be handled by the procedure team with full medication disclosure, not delayed by portal messages or seller advice.
  • Do not stretch vials, split pens, restart after missed doses, or change dosing around anesthesia unless the responsible clinician gives written instructions.

Non-GLP products and red flags

PT-141, methylene blue, sermorelin, NAD+, glutathione, and topicals still matter

Non-GLP products can still affect a procedure conversation. PT-141/bremelanotide should prompt blood-pressure and cardiovascular review. Low-dose oral methylene blue needs medication-list screening for serotonergic drugs and G6PD risk. Sermorelin, NAD+, and glutathione may raise lab, injection, allergy, supplement, or pharmacy-quality questions. Topical GHK-Cu and NAD+ should not be applied to irritated, infected, open, or freshly treated skin unless a clinician approves.

  • Tell clinicians about antidepressants, opioids, stimulants, blood-pressure medicines, anticoagulants, diabetes medicines, sedatives, supplements, and allergy or asthma history.
  • Contact the procedure team promptly for fever, infection, severe vomiting, dehydration, chest pain, fainting, trouble breathing, severe allergic symptoms, or symptoms the team marked urgent.
  • Avoid sellers promoting “procedure recovery peptides,” research-use vials, no-prescription products, or dosing charts that bypass the surgeon, anesthesiologist, prescriber, or pharmacist.

Patient safety checklist

Questions to ask before a procedure while using peptide therapy

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

Which products should I disclose: GLP-1s, branded pens, compounded prescriptions, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, methylene blue, hormones, supplements, or topicals?

✓

Does the procedure involve local anesthesia, moderate sedation, deep sedation, general anesthesia, endoscopy, dental work, imaging, cosmetic treatment, or post-procedure wound care?

✓

Do nausea, vomiting, reflux, constipation, dehydration, low intake, diabetes medicines, dose escalation, or kidney risk change the anesthesia or fasting plan?

✓

Should any instructions come from the surgeon, anesthesiologist, proceduralist, dentist, peptide prescriber, pharmacist, primary care, or specialist?

✓

What written plan applies if a dose is missed, the procedure is delayed, an infection develops, a new medicine is prescribed, or a refill arrives late?

✓

Do blood thinners, aspirin, NSAIDs, opioids, sedatives, antibiotics, antidepressants, stimulants, blood-pressure medicines, diabetes medicines, or supplements need review?

✓

Which symptoms should use routine portal messaging, same-day clinician guidance, urgent care, emergency services, or poison control rather than waiting?

✓

Does the clinic avoid guaranteed clearance, self-hold windows, restart schedules, research-use peptides, and no-prescription recovery products?

FAQs

Short answers for patients

Should I tell my surgeon or anesthesiologist about peptide therapy?

Yes. Tell the procedure team about the active ingredient, route, dose or use timing, pharmacy label, side effects, allergies, supplements, compounded status, and any diabetes, blood-pressure, blood-thinner, sedative, or pain medicines.

Should I stop peptide therapy before surgery?

Do not decide on your own. The safest answer depends on the product, procedure, anesthesia plan, symptoms, dose changes, diabetes status, kidney or dehydration risk, and the clinicians responsible for the procedure and prescription.

Why are GLP-1 medicines discussed before anesthesia?

GLP-1 medicines such as semaglutide and tirzepatide can delay stomach emptying and cause GI symptoms. That can matter for sedation, aspiration-risk planning, fasting instructions, diabetes medicines, and whether elective procedures need extra precautions.

Do non-GLP peptides matter before a procedure?

They can. PT-141 raises blood-pressure and cardiovascular questions, methylene blue requires interaction and G6PD screening, injectable products may raise pharmacy or allergy questions, and topical products can matter for skin procedures or open skin.

Can I use research peptides for surgery recovery?

Avoid no-prescription or research-use peptides marketed for human recovery. Discuss recovery goals, wound-healing questions, pharmacy sourcing, infection risk, and medication timing with the surgeon, proceduralist, prescriber, and pharmacist.

What procedure symptoms need urgent help?

Use urgent pathways for chest pain, trouble breathing, fainting, confusion, severe dehydration, persistent vomiting, severe abdominal pain, severe allergic symptoms, uncontrolled bleeding, spreading infection, or symptoms your procedure team labeled urgent.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

American Society of Anesthesiologists: 2024 multi-society GLP-1 clinical practice guidanceMedlinePlus: Tests and visits before surgeryMedlinePlus: Anesthesia - what to ask your doctorDailyMed: Wegovy (semaglutide) prescribing informationDailyMed: Zepbound (tirzepatide) prescribing informationFDA: FDA's concerns with unapproved GLP-1 drugs used for weight lossPeptide12: GLP-1 surgery and anesthesia questionsPeptide12: peptide therapy before dental workPeptide12: reading peptide medication labelsPeptide12: missed-dose plan questionsPeptide12: primary care coordinationPeptide12: medication interaction reviewPeptide12: How online peptide therapy works